Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
16-30 April 2008  
Untitled Document
Sections

Market
Management
Research
Pharma Life
Pharma Packaging
Express Biotech

Services
Open Forum
Appointments
Subscribe/Renew
Archives
Editorial Calendar
Media Kit
Contact Us
Network Sites
Express Computer
CIO Decisions
Express Channel Business
Express Hospitality
Express TravelWorld
feBusiness Traveller
Exp. Healthcare Mgmt.
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express




    RESEARCH - Expertise for Drug Development
 

Good bacteria for good life
With the global market for probiotic products showing good growth, therapeutic usage is also slowly gaining acceptance in the Indian market. Sushmi Dey finds out what research is being done

Gemcitabine as a chemotherapeutic agent in NSCLC
An antimetabolite, gemcitabine (GemzarR), had been approved by the US Food and Drug Aministration (FDA) in 1996 for use in first line treatment of different stages of pancreatic adenocarcinomas.

Untitled Document
Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.